A discussion on formulation development, contract services, and some of the critical considerations when moving from molecule ...

Price differences are especially pertinent with these weight loss drugs, which are officially called glucagon-like peptide-1 ...

Proposals for drug exclusivities and feeble measures to combat drug shortages are unlikely to boost innovation, say some ...

The U.S. Food and Drug Administration’s (FDA’s) evolving guidance on Computer Software Assurance and AI/ML-Based Software ...

As the pharma sector braces for sector-specific tariffs from President Trump, what could the impact look like on supply ...

Scientific experts are concerned about what role vaccines will play in US public health strategy under the Trump ...

Piramal Pharma invests $90m to expand its two US facilities, enhancing manufacturing capabilities for sterile injectables and ...

Drug discovery has traditionally been slow, expensive and prone to failure, but AI and machine learning are set to change all ...

Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US.

AbbVie gains control of an in vivo CAR-T therapy that could overcome limitations with currently approved autologous ...

The sale caps a difficult time for zilovertamab and ONCT-808 under Oncternal’s ownership. Zilovertamab was deprioritised by ...

A new podcast from industry experts MarketScan explains why social determinants of health are critical to patient care.